��������

Franklin R. Cockerill, III, MD, FACP, FACCP, FAAM, FIDSA is an internationally recognized microbiologist, known for his exceptional leadership, research and development skills. He most recently served as the chief medical officer and as a director of the board of Analyte Health, located in Chicago.

Prior to that, he served as the company’s CEO, a tenure in which he was awarded the “Ten Most Promising Telemedicine Solution Providers of 2017” distinction by Healthcare Tech Outlook, as well as the Halfpenny G-2 Lab Innovation Award for novel integration of laboratory services into the telehealth ecosystem.

Over the course of his extensive career, Dr. Cockerill was also endowed professor and chair of the Department of Laboratory Medicine and Pathology, Mayo Clinic, and president and CEO of Mayo Medical Laboratories (MML). He is board-certified in internal medicine, infectious diseases and clinical microbiology, with research interests ranging from basic discovery to applied science, with a special emphasis on the phenotypic and genotypic identification of antimicrobial resistance.